Verfahren zur Erkennung von Brustkrebsbiomarkern, Mikrofluidisches System, Kit und Verwendungen davon
EP4800393
2. September 2026
Anmelder: Universidade de Aveiro, Inesc Microsistemas E Nanotecnologias - Instituto de Engenharia de Sistemas e Computadores para os Microsistemas e as Nanotecnologias 🇵🇹
Details
- Veröffentlichungs-Nr.
- EP4800393
- Anmeldetag
- 27. Februar 2025
- Veröffentlichung
- 2. September 2026
- Rechtsraum
- EP
- IPC
- G01N33/574
Abstract
The present disclosure relates to point-of-care diagnostics, specifically to a microfluidic sandwich immunoassay for the detection of breast cancer biomarkers (for ex: HER2 biomarker) in biological samples, utilizing dual ionic liquid all-aqueous extraction for enhanced sensitivity and fluorescence-based quantification. This solution enables highly sensitive, low-volume, and point-of-care diagnostics, offering an unexpectedly lower limit of detection (LoD) compared to conventional methods.
Anmelder
- Firmen
- Universidade de Aveiro
Inesc Microsistemas E Nanotecnologias - Instituto de Engenharia de Sistemas e Computadores para os Microsistemas e as Nanotecnologias - Land
- 🇵🇹 Portugal